Entity Common Stock, Shares Outstanding of CytoMed Therapeutics Ltd from 01 May 2023 to 31 Dec 2024

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
CytoMed Therapeutics Ltd quarterly Entity Common Stock, Shares Outstanding in shares history and change rate from 01 May 2023 to 31 Dec 2024.
  • CytoMed Therapeutics Ltd Entity Common Stock, Shares Outstanding for the quarter ending 31 Dec 2024 was 11,540,000.
Source SEC data
View on sec.gov
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Change (%)

CytoMed Therapeutics Ltd Quarterly Entity Common Stock, Shares Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2024 11,540,000 31 Dec 2024 20-F 28 Apr 2025 2024 FY
Q1 2024 11,540,000 +10,672 +0.09% 22 Apr 2024 20-F 22 Apr 2024 2023 FY
Q1 2023 11,529,328 01 May 2023 20-F 01 May 2023 2022 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.